The Serum Institute of India is legally compelled to ship coronavirus vaccine to global vaccine sharing facility Covax, its co-lead Gavi has told Reuters, a provision that could complicate the firm&rs...

  India's drug regulator DCGI has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date. In a letter to the Ser...

India’s drug regulator has allowed the AstraZeneca Covid-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document r...

Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of COVID-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year. In Augus...

Boris Johnson, who was supposed to be the chief guest at the Republic Day celebrations in Delhi on January 26 but had to postpone the visit because of a surge in coronavirus cases in the UK, is expect...

The Delhi High Court Thursday directed Serum Institute of India and Bharat Biotech to disclose their capacities to manufacture Covaxin, Covishield vaccines. The high court also asked the Centre to ex...

The government has placed orders for one crore additional doses of Covishield from Serum Institute of India and 45 lakh more doses of Covaxin from Bharat Biotech, officials of the two vaccine makers s...

A blaze on Thursday at the Serum Institute of India killed five people but the world’s biggest vaccine maker said it would not affect production of the AstraZeneca coronavirus vaccine. At least...

Maharashtra Deputy Chief Minister Ajit Pawar said the state government has ordered a probe into the blaze. The fire, which broke out at 2.45 pm on the fourth and fifth floors of the SEZ 3 building in...

Nine persons were evacuated from a building in the Serum Institute of India's Manjari premises here after a fire broke out there on Thursday, police said. There would be no loss of Covishield pro...